Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Graph cut optimization for the Mumford-Shah model
In this paper, we introduce a Graph Cut Based Level Set (GCBLS) formulation that incorporates graph cuts to optimize the curve evolution energy function presented earlier by Chan and Vese. We present… Expand
The case for hackathons in dermatology
A central goal of Hacking Dermatology, one of the first ever dermatology-focused hackathons, is to build a community of people interested in collaborating to improve the current standards of care for… Expand
Awareness of Tobacco-Related Health Harms among Vulnerable Populations in Bangladesh: Findings from the International Tobacco Control (ITC) Bangladesh Survey
- P. Driezen, A. Abdullah, +5 authors Steve Xu
- International journal of environmental research…
- 25 August 2016
This study assessed the knowledge of the harmful effects of tobacco use among vulnerable populations in Bangladesh and whether vulnerability was associated with the presence of complete home smoking… Expand
Tobacco Control Policies in the Republic of Korea and the Methods of the ITC Korea Surveys
Policies that promote the social unacceptability of smoking may also result in smoking-related stigma. The aim of this study is to evaluate how norms against smoking and socioeconomic status (SES)… Expand
Prevalence of lower harm perceptions of cigarette product characteristics: findings from 10 low-middle-income countries from the ITC project
Creative initiative involves clinicians in innovation
Drs. Lilit Garibyan, Steve Xu and Kachiu C. Lee highlight a grassroots initiative that encourages physicians to become more involved in innovation in dermatology.
Nuogen Pharma: Innovation in the fight against itch
Nuogen Pharma’s mission is to deliver the first FDA-approved anti-itch medication for chronic pruritus of unknown origin (CPUO) and other chronic itch conditions.
Spotlight on Dermira and the QBREXZA story
Hans Hofland, Ph.D, and Dr. Steve Xu shine a spotlight on Dermira and its novel topical medicine indicated for primary axillary hyperhidrosis in patients 9 years of age and older.